Sahab Danesh, DPM
Primary Podiatric Medicine · Santa Rosa, CANPI 1538655279
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for primary podiatric medicine clinicians in CA, where the typical reported total is $887.
Across 13 payments — averaging $26.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$58
- Organogenesis Inc.$50
- Stryker$49
- Linvatec Corporation$33
- Averitas Pharma Inc.$30
- Nevro Corp.$26
- plus $95 from 5 others
What the payments were for
- Food & beverage$341100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 2 | $58 |
| Organogenesis Inc. | 2 | $50 |
| Stryker | 1 | $49 |
| Linvatec Corporation | 1 | $33 |
| Averitas Pharma Inc. | 1 | $30 |
| Nevro Corp. | 1 | $26 |
| Medtronic | 1 | $26 |
| Bioventus LLC | 1 | $18 |
| Abbott | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$341 in reported general payments places this provider in the 40th percentile of 59 primary podiatric medicine providers in California.
See all primary podiatric medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 94 | $1,321 |
| Ciclopirox | 19 | $789 |
| Clotrimazole | 11 | $183 |
| Doxycycline Hyclate | 20 | $121 |
| Cephalexin | 23 | $43 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Santa Rosa
- James WangLos Angeles$250K
- Adam ShapiroUpland$21K
- Ali GhorbanifarajzadehBakersfield$17K
- Abid ChaudhryArleta$11K
- Matthew GarrisonSacramento$7K
- Linh HuynhTurlock$7K
- Yvette CanabaSantee$5K
- David KhakshoorLos Angeles$4K
- Katrina SergeevaVista$4K
- Christyn MarshallDanville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.